Non-Melanoma Skin Cancer
Oncology·MeSH: Carcinoma, Bronchogenic
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
3 drugs in development·1 company·2 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Non-Melanoma Skin Cancer?
BioSniper tracks 3 drugs in development for Non-Melanoma Skin Cancer across 1 company.
How many clinical trials target Non-Melanoma Skin Cancer?
There are 2 clinical trials targeting Non-Melanoma Skin Cancer tracked by BioSniper.
What is the prevalence of Non-Melanoma Skin Cancer?
The estimated prevalence of Non-Melanoma Skin Cancer is approximately 75.0 per 100,000 population.
Deep-dive into Non-Melanoma Skin Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis